The invention relates to sphingosine derivative compounds, like D-erythro-sphingosine 1-phosphate (S1P), to be used as immunomodulators in a microbicidal treatment of infections derived from bacteria and specifically Mycobacterium tuberculosis. Such ...

Fraziano, M., Garg, S., Volpe, E., Martino, A., DE VITO, P., Baldini, P., et al. (2002). Immunoregulatory compounds.

Immunoregulatory compounds

FRAZIANO, MAURIZIO;DE VITO, PAOLO;BALDINI, PATRIZIA;COLIZZI, VITTORIO
2002-01-01

Abstract

The invention relates to sphingosine derivative compounds, like D-erythro-sphingosine 1-phosphate (S1P), to be used as immunomodulators in a microbicidal treatment of infections derived from bacteria and specifically Mycobacterium tuberculosis. Such ...
Università degli Studi di Roma "Tor Vergata"
2002
PCT/IT02/00740
Settore MED/04 - PATOLOGIA GENERALE
English
Fraziano, M; Garg, S; Volpe, E; Martino, A; DE VITO, P; Baldini, P; Galati, D; Auricchio, G; Ciaramella, A; Colizzi, V
Brevetti
Fraziano, M., Garg, S., Volpe, E., Martino, A., DE VITO, P., Baldini, P., et al. (2002). Immunoregulatory compounds.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/44135
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact